Literature DB >> 7947223

Terbinafine and erythema multiforme.

J M McGregor, M H Rustin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7947223     DOI： 10.1111/j.1365-2133.1994.tb08573.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Topical terbinafine in the treatment of cutaneous leishmaniasis: triple blind randomized clinical trial.

Authors:  Saeedeh Farajzadeh; Amireh Heshmatkhah; Behrooz Vares; Elham Mohebbi; Azadeh Mohebbi; Mahin Aflatoonian; Sana Eybpoosh; Iraj Sharifi; Mohammad Reza Aflatoonian; Simin Shamsi Meymandi; Ali Reza Fekri; Mahshid Mostafavi
Journal:  J Parasit Dis       Date:  2015-01-22

2.  [Facial pigmentation following therapy with terbinafine].

Authors:  K Breuer; B Völker; R Gutzmer; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

3.  Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.

Authors:  A Mallat; E S Zafrani; J M Metreau; D Dhumeaux
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 4.  Management of onychomycoses.

Authors:  M Niewerth; H C Korting
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.